{"url_path":"/sec/cntb/8-k/2026-05-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1835268/0001835268-26-000019-index.html","accession_number":"0001835268-26-000019","cik":"0001835268","ticker":"CNTB","issuer_name":"Connect Biopharma Holdings Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1835268/0001835268-26-000019-index.html","primary_entity_key":"0001835268","primary_entity_name":"Connect Biopharma Holdings Ltd"},"word_count":76,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press Release of the Company, dated](cntbq12026earningsrelease.htm)[Ma](cntbq12026earningsrelease.htm)[y 12, 2026](cntbq12026earningsrelease.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nCONNECT BIOPHARMA HOLDINGS LIMITED\n\nDate:May 12, 2026By:/s/ Lisa Peraza\n\nName:Lisa Peraza\n\nTitle:Senior Vice President, Finance"}